)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
LakeShore Biopharma (LSB) investor relations material
LakeShore Biopharma H2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2024 earnings summary14 Aug, 2024
Executive summary
LakeShore Biopharma is a global biopharmaceutical company focused on vaccines and biologics for infectious diseases and cancer, with its main revenue from the YSJA rabies vaccine in China. As of March 31, 2024, over 104 million doses have been administered, and the company has a robust pipeline of clinical and preclinical candidates leveraging its proprietary PIKA immunomodulating technology.
The company operates primarily in China but also has subsidiaries in Singapore, the US, Hong Kong, and the Philippines. It is listed on Nasdaq and completed a business combination in March 2023, followed by a $40 million private placement in February 2024.
Financial highlights
Revenue for the fiscal year ended March 31, 2024, was RMB573.4 million ($80.8 million), a 16.6% decrease from the prior year, mainly due to COVID-related disruptions impacting manufacturing and sales volume.
Gross profit was RMB455.7 million ($64.2 million), with a gross margin of 79.5%, up from 77.7% the previous year, driven by higher unit prices and lower delivery costs.
Net loss widened to RMB433.5 million ($61.1 million) from RMB145.5 million in the prior year, primarily due to increased impairment losses (RMB157.4 million), higher general and administrative expenses, and continued R&D investment.
R&D expenses were RMB302.8 million ($42.7 million), down 5% year-over-year, with a shift in focus from COVID-19 vaccines to rabies and HBV candidates.
Cash and cash equivalents at year-end were RMB246.4 million ($34.7 million), with total outstanding bank loans and borrowings of RMB417.5 million ($58.8 million).
Outlook and guidance
The company expects to complete Phase III trials for its PIKA rabies vaccine in Southeast Asia in 1H2025 and to advance clinical studies in China in 2025.
Management plans to expand manufacturing capacity in Shenyang, China, and continue international market expansion, particularly in Southeast Asia.
The company anticipates continued investment in R&D and commercialization, with a focus on leveraging its PIKA platform for new product launches.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
LakeShore Biopharma Company Limited is a biopharmaceutical company focused on the development of novel therapeutics. It engages in drug discovery and clinical research across various therapeutic areas, including infectious diseases and oncology. The company seeks to commercialize innovative treatments through internal R&D and partnerships. It is headquartered in George Town, Cayman Islands, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage